Despite modern imaging and genetic testing, diagnosing amyotrophic lateral sclerosis (ALS) remains challenging, particularly ...
16 天on MSN
Simple blood test gets green light by FDA to improve early detection of Alzheimer’s disease
Simple blood test gets green light by FDA to improve early detection of Alzheimer’s disease - Millions of Americans are living with Alzheimer’s and hundreds of thousands are diagnosed each year ...
Get practical TPMS troubleshooting tips to diagnose sensor faults, flashing lights, and wiring issues quickly and accurately.
The test is intended for adults 55 and older in the United States who are showing signs or symptoms of cognitive decline.
A new blood test that could help doctors identify whether a patient has Alzheimer’s disease was cleared by the FDA last week.
The "access flywheel" is four tightly linked moves any corporate-clinic partnership can use to expand early-detection ...
A new study may finally change how amyotrophic lateral sclerosis (ALS) is diagnosed. Scientists from UCLA Health and the ...
(CNN) — The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of ...
Pharmaceutical Technology on MSN
FDA greenlight for Roche’s Alzheimer’s disease test sparks care paradigm shift
The US Food and Drug Administration’s (FDA) recent clearance of Roche’s blood-based Alzheimer’s disease test will boost ...
Tired without answers? Years‑long limbo may be nearing its end as scientists spotlight measurable clues behind relentless ...
The Galleri blood test by Grail can be given annually and looks for the DNA ‘fingerprint’ of more than 50 deadly cancers.
An important scientific study published in The Lancet shows the strong public health impact of deploying molecular diagnostics closer to the people.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果